Art

J-GLOBAL ID：201002298839206579   Reference number：10A0471697

Urban Aerosols Induce Pro-inflammatory Cytokine Production in Macrophages and Cause Airway Inflammation in Vivo

都市域エアロゾルはマクロファージにおいて炎症性サイトカイン産生を誘導しin vivoで気道炎症を引き起こす

Author (37)： YOSHIDA Tokuyuki (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  YOSHIDA Tokuyuki (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  YOSHIOKA Yasuo (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  YOSHIOKA Yasuo (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  YOSHIOKA Yasuo (The Center for Advanced Medical Engineering and Informatics, Osaka Univ.) ,  FUJIMURA Maho (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  FUJIMURA Maho (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  KAYAMURO Hiroyuki (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  KAYAMURO Hiroyuki (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  YAMASHITA Kohei (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  YAMASHITA Kohei (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  HIGASHISAKA Kazuma (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  HIGASHISAKA Kazuma (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  NAKANISHI Ryosuke (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  NAKANISHI Ryosuke (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  MORISHITA Yuki (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  MORISHITA Yuki (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  NABESHI Hiromi (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  NABESHI Hiromi (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  YAMASHITA Takuya (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  YAMASHITA Takuya (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  MUROI Masashi (Res. Inst. of Pharmaceutical Sciences, Musashino Univ.) ,  TANAMOTO Kenichi (Res. Inst. of Pharmaceutical Sciences, Musashino Univ.) ,  NAGANO Kazuya (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  ABE Yasuhiro (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  KAMADA Haruhiko (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  KAMADA Haruhiko (The Center for Advanced Medical Engineering and Informatics, Osaka Univ.) ,  KAWAI Yuichi (Graduate School of Pharmaceutical Sciences, Kobe-Gakuin Univ.) ,  MAYUMI Tadanori (Graduate School of Pharmaceutical Sciences, Kobe-Gakuin Univ.) ,  ITOH Norio (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  YOSHIKAWA Tomoaki (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  YOSHIKAWA Tomoaki (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  TSUNODA Shinichi (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  TSUNODA Shinichi (The Center for Advanced Medical Engineering and Informatics, Osaka Univ.) ,  TSUTSUMI Yasuo (Dep. of Toxicology and Safety Sci., Graduate School of Pharmaceutical Sciences, Osaka Univ.) ,  TSUTSUMI Yasuo (Lab. of Pharmaceutical Proteomics, National Inst. of Biomedical Innovation (NiBio)) ,  TSUTSUMI Yasuo (The Center for Advanced Medical Engineering and Informatics, Osaka Univ.)
Material： Biological and Pharmaceutical Bulletin  (Biological & Pharmaceutical Bulletin)
Volume： 33  Issue： 5  Page： 780-783 (J-STAGE)  Publication year： 2010 
JST Material Number： S0989A  ISSN： 0918-6158  CODEN： BPBLEO  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： metropolitan area ,...
Semi thesaurus term： IL-1 beta ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A0471697&from=J-GLOBAL&jstjournalNo=S0989A") }}

JST classification (4)： Examination and measurement of granular matter  (SB03060E) ,  Cytokines  (EB08090G) ,  Influence on humans  (EE05050C) ,  Immunologic diseases,allergic diseases in general.  (GD04010C)

Reference (30)：

• 1) Sandstrom T., Cassee F. R., Salonen R., Dybing E., Toxicol. Appl. Pharmacol., 207, 261—268 (2005).
• 2) Nautiyal J. 3rd, Garg M. L., Kumar M. S., Khan A. A., Thakur J. S., Kumar R., Int. J. Environ. Res. Public Health, 4, 268—282 (2007).
• 3) Dockery D. W., Ann. Epidemiol., 19, 257—263 (2009).
• 4) Hoek G., Brunekreef B., Goldbohm S., Fischer P., van den Brandt P. A., Lancet, 360, 1203—1209 (2002).
• 5) D'Amato G., Liccardi G., D'Amato M., Cazzola M., Eur. Respir. J., 20, 763—776 (2002).

Terms in the title (6)： 都市域エアロゾル ,  マクロファージ ,  炎症 ,  サイトカイン産生 ,  誘導 ,  気道炎症